Diagnostics

Natus Sensory is bringing back the trusted Otometrics name to unify its hearing and balance portfolio, a strategic move with deep market implications.

As Varex prepares its Q2 report, investors watch to see if booming industrial sales and medical innovations can sustain its impressive market momentum.

With rising cancer rates, Utepreva's innovative sampler promises more accurate and comfortable tissue collection, potentially transforming early diagnosis.

A new study reveals a decade-long partnership is revolutionizing endodontics, with research cited 72% more than typical NIH-funded studies.

IntraNerve and AI startup Piramidal are building an 'AI co-pilot' to analyze EEG data in seconds, promising faster diagnoses for critical care patients.

A $500K grant accelerates a novel therapy that dismantles tumor defenses, offering new hope for patients with hard-to-treat gastroesophageal cancers.

A new imaging tool eliminates background noise, offering a revolutionary, high-definition view into the cellular processes that drive life and disease.

With its fiscal 2026 results imminent, STERIS faces high expectations amid market pressures, offering a key indicator for the global healthcare sector.

Remix Therapeutics' first-in-class drug REM-422 targets a rare cancer at its genetic source, with pivotal data set for a major oncology conference.

A new company is betting you'll add a daily lung health routine to your day. With a new inhaler, Climatic wants to do for breathing what we did for hydration.

New long-term data for FLT201 gene therapy could signal a paradigm shift from lifelong treatments for patients with Gaucher disease type 1.

As COVID revenues fall, BioNTech bets its future on a robust oncology pipeline. The upcoming Q1 2026 report will reveal the financial health of this pivot.

A new alliance between UltraGreen and LifeSignals will bring advanced wearable heart monitors to a global market, tackling rising cardiovascular disease.

Audien Hearing expands to 1,000+ Target stores, making FDA-regulated hearing aids more accessible and affordable than ever. A new era for health retail begins.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.

The medtech giant posts Q1 growth and secures critical EU approvals for new devices, navigating post-pandemic shifts and geopolitical headwinds with strong cash flow.

A new scholarship from Antech & Vet Set Go offers funds and mentorship to aspiring vets, aiming to ease the path and combat a growing industry shortage.

A new liquid biopsy using viral DNA gets FDA fast-track status, promising to detect liver cancer recurrence more than five months earlier than imaging scans.

A new partnership aims to develop a diagnostic test for a hidden cancer biomarker, potentially unlocking a targeted therapy for patients with grim prognoses.

With backing from Mayo Clinic, a startup's AI promises to slash biomarker analysis from weeks to minutes, accelerating cancer care and drug discovery.